{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:45:16Z","timestamp":1793303116446,"version":"4.5.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"14","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["JAHA"],"published-print":{"date-parts":[[2019,7,16]]},"abstract":"<jats:sec xml:lang=\"en\">\n            <jats:title>Background<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              A risk score for secondary prevention after myocardial infarction (Thrombolysis in Myocardial Infarction Risk Score for Secondary Prevention [TRS2P]), based on 9 established clinical factors, was recently developed from the\n              <jats:styled-content style=\"fixed-case\">TRA<\/jats:styled-content>\n              2\u00b0P\u2010\n              <jats:styled-content style=\"fixed-case\">TIMI<\/jats:styled-content>\n              50 (Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) trial. We aimed to evaluate the performance of\n              <jats:styled-content style=\"fixed-case\">TRS<\/jats:styled-content>\n              2P for predicting long\u2010term outcomes in real\u2010world patients presenting for coronary angiography.\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec xml:lang=\"en\">\n            <jats:title>Methods and Results<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              A retrospective analysis of 13\u00a0593 patients referred to angiography for the assessment or treatment of coronary disease was performed. Risk stratification for 10\u2010year major adverse cardiovascular events was performed using the\n              <jats:styled-content style=\"fixed-case\">TRS<\/jats:styled-content>\n              2P, divided into 6 categories (0 to \u22655 points), and in relation to the presenting coronary syndrome. All clinical variables, except prior coronary artery bypass grafting, were independent risk predictors. The annualized incidence rate of major adverse cardiovascular events increased in a graded manner with increasing\n              <jats:styled-content style=\"fixed-case\">TRS<\/jats:styled-content>\n              2P, ranging from 1.65 to 16.6 per 100\u00a0person\u2010years (\n              <jats:italic>P<\/jats:italic>\n              <jats:sub>trend<\/jats:sub>\n              &lt;0.001). Compared with the lowest\u2010risk group (risk indicators=0), the hazard ratios (95% CIs) for 10\u2010year major adverse cardiovascular events were 1.60 (95% CI, 1.36\u20131.89), 2.58 (95% CI, 2.21\u20133.02), 4.31 (95% CI, 3.69\u20135.05), 6.43 (95% CI, 5.47\u20137.56), and 10.03 (95% CI, 8.52\u201311.81), in those with 1, 2, 3, 4 and \u22655 risk indicators, respectively. Risk gradation was consistent among individual clinical end points.\n              <jats:styled-content style=\"fixed-case\">TRS<\/jats:styled-content>\n              2P showed reasonable discrimination with C\u2010statistics of 0.693 for major adverse cardiovascular events and 0.758 for mortality. The graded relationship between the risk score and event rates was observed in both patients presenting with acute and nonacute coronary syndromes.\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec xml:lang=\"en\">\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              The use of\n              <jats:styled-content style=\"fixed-case\">TRS<\/jats:styled-content>\n              2P, a simple risk score based on routinely collected variables, enables risk stratification in patients undergoing coronary angiography. Its predictive value was demonstrated in a real\u2010world setting with long\u2010term follow\u2010up and regardless of the acuity of coronary presentation.\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.1161\/jaha.119.012433","type":"journal-article","created":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T14:19:31Z","timestamp":1562249971000},"update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":15,"title":["Long\u2010Term Risk Stratification of Patients Undergoing Coronary Angiography According to the Thrombolysis in Myocardial Infarction\u00a0Risk Score for Secondary Prevention"],"prefix":"10.1161","volume":"8","author":[{"given":"Barak","family":"Zafrir","sequence":"first","affiliation":[{"name":"Department of Cardiology Lady Davis Carmel Medical Center Haifa Israel"},{"name":"Faculty of Medicine Technion Israel Institute of Medicine Haifa Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salim","family":"Adawi","sequence":"additional","affiliation":[{"name":"Department of Cardiology Lady Davis Carmel Medical Center Haifa Israel"},{"name":"Faculty of Medicine Technion Israel Institute of Medicine Haifa Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marah","family":"Khalaily","sequence":"additional","affiliation":[{"name":"Faculty of Medicine Technion Israel Institute of Medicine Haifa Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronen","family":"Jaffe","sequence":"additional","affiliation":[{"name":"Department of Cardiology Lady Davis Carmel Medical Center Haifa Israel"},{"name":"Faculty of Medicine Technion Israel Institute of Medicine Haifa Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amnon","family":"Eitan","sequence":"additional","affiliation":[{"name":"Department of Cardiology Lady Davis Carmel Medical Center Haifa Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ofra","family":"Barnett\u2010Griness","sequence":"additional","affiliation":[{"name":"Statistical Unit Lady Davis Carmel Medical Center Haifa Israel"},{"name":"Department of Community Medicine and Epidemiology Lady Davis Carmel Medical Center Haifa Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walid","family":"Saliba","sequence":"additional","affiliation":[{"name":"Department of Community Medicine and Epidemiology Lady Davis Carmel Medical Center Haifa Israel"},{"name":"Faculty of Medicine Technion Israel Institute of Medicine Haifa Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1606915"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0908610"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000558"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu505"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.284.7.835"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.163.19.2345"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2011-300129"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.852749"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2012.01.014"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.019861"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1200933"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.008426"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2018.03.026"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/clc.23131"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcvp\/pvy004"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.11.070"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/sim.6428"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.297.11.1197"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2003.10.006"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2012.12.020"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2008.563"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx710"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)17018-9"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy394"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1177\/2048872617716388"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2013.725"}],"container-title":["Journal of the American Heart Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/JAHA.119.012433","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T11:06:29Z","timestamp":1715598389000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/JAHA.119.012433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,16]]},"references-count":27,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2019,7,16]]}},"alternative-id":["10.1161\/JAHA.119.012433"],"URL":"https:\/\/doi.org\/10.1161\/jaha.119.012433","relation":{},"ISSN":["2047-9980"],"issn-type":[{"value":"2047-9980","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,16]]},"assertion":[{"value":"2019-02-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-06-11","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-07-04","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e012433"}}